In addition, among detectable specimens, compared with NSCLC, the expression frequency of PD-L1 in SCLC is significantly lower (25, 26), with only about 25% of SCLC patients showing positive PD-L1 expression in tumor cells (27). This evidence concerns the gene CD274 and neoplasm.